Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2008(14): 2158-2162
DOI: 10.1055/s-2008-1067149
DOI: 10.1055/s-2008-1067149
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
A Practical Synthesis of the C1-C9 Fragment of Dictyostatin
Further Information
Received
5 March 2008
Publication Date:
18 June 2008 (online)
Publication History
Publication Date:
18 June 2008 (online)

Abstract
A stereoselective synthesis of the C1-C9 fragment of (-)-dictyostatin has been achieved by use of a titanium(IV) chloride mediated chelation-controlled Mukaiyama aldol reaction and two modified Horner-Wadsworth-Emmons olefinations (Roush-Masamune and Still-Gennari).
Key words
antitumor agents - stereoselective synthesis - aldol reactions - titanium - olefination
-
1a
Isbrucker RA.Cummins J.Pomponi SA.Longley RE.Wright AE. Biochem. Pharmacol. 2003, 66: 75 -
1b
Madiraju C.Edler MC.Hamel E.Raccor BS.Balachandran R.Zhu G.Giuliano KA.Vogt A.Shin Y.Fournier J.-H.Fukui Y.Brückner AM.Curran DP.Day BW. Biochemistry 2005, 44: 15053 - 2
Paterson I.Britton R.Delgado O.Wright AE. Chem. Commun. 2004, 632 -
3a
Paterson I.Britton R.Delgado O.Meyer A.Poullennec KG. Angew. Chem. Int. Ed. 2004, 43: 4629 -
3b
Shin Y.Fournier J.-H.Fukui Y.Brückner AM.Curran DP. Angew. Chem. Int. Ed. 2004, 43: 4634 -
3c
O’Neil GW.Phillips AJ. J. Am. Chem. Soc. 2006, 128: 5340 -
3d
Ramachandran PV.Srivastava A.Hazra D. Org. Lett. 2007, 9: 157 -
4a
Shin Y.Fournier J.-H.Balachandran R.Madiraju C.Raccor BS.Zhu G.Edler MC.Hamel E.Day BW.Curran DP. Org. Lett. 2005, 7: 2873 -
4b
Fukui Y.Brückner AM.Shin Y.Balachandran R.Day BW.Curran DP. Org. Lett. 2006, 8: 301 -
4c
Paterson I.Gardner NM.Poullennec KG.Wright AE. Bioorg. Med. Chem. Lett. 2007, 17: 2443 -
4d
Jung W.-H.Harrison C.Shin Y.Fournier J.-H.Balachandran R.Raccor BS.Sikorski RP.Vogt A.Curran DP.Day BW. J. Med. Chem. 2007, 50: 2951 -
4e
Shin Y.Fournier J.-H.Brückner A.Madiraju C.Balachandran R.Raccor BS.Edler MC.Hamel E.Sikorski RP.Vogt A.Day BW.Curran DP. Tetrahedron 2007, 63: 8537 -
5a
Shin Y.Choy N.Balachandran R.Madiraju C.Day BW.Curran DP. Org. Lett. 2002, 4: 4443 -
5b
Paterson I.Gardner NM. Chem. Commun. 2007, 49 -
6a
O’Neil GW.Phillips AJ. Tetrahedron Lett. 2004, 45: 4253 -
6b
Kangani CO.Brückner AM.Curran DP. Org. Lett. 2005, 7: 379 -
6c
Jägel J.Maier ME. Synlett 2006, 693 -
6d
Prusov E.Röhm H.Maier ME. Org. Lett. 2006, 8: 1025 -
6e
Baba VS.Das P.Mukkantib K.Iqbal J. Tetrahedron Lett. 2006, 47: 7927 -
6f
Moura-Letts G.Curran DP. Org. Lett. 2007, 9: 5 -
6g
Saibaba V.Sampath A.Mukkanti K.Iqbal J.Das P. Synthesis 2007, 2797 -
6h
Dilger AK.Gopalsamuthiram V.Burke SD. J. Am. Chem. Soc. 2007, 129: 16273 -
6i
Sharon O.Monti C.Gennari C. Tetrahedron 2007, 63: 5873 -
6j
Monti C.Sharon O.Gennari C. Chem. Commun. 2007, 4271 - 8
White JD.Kawasaki M. J. Org. Chem. 1992, 57: 5292 - 9
Dess DB.Martin JC. J. Am. Chem. Soc. 1991, 113: 7277 -
10a
Gennari C.Cozzi PG. Tetrahedron 1988, 44: 5965 -
10b
Gennari C. In Comprehensive Organic Synthesis Vol. 2:Trost BM.Fleming I. Pergamon; Oxford: 1991. p.629 -
10c
Gennari C. In Encyclopedia of Reagents for Organic SynthesisPaquette LA. John Wiley & Sons; Chichester: 1995. p.939 -
11a
Horita K.Yoshioka T.Tanaka T.Oikawa Y.Yonemitsu O. Tetrahedron 1986, 42: 3021 -
11b
Hydrogenolysis with Pd/C in EtOAc at r.t. (see ref. 11c) resulted in concurrent extensive deprotection of the TBS groups.
-
11c
Ikawa T.Hattori K.Sajiki H.Hirota K. Tetrahedron 2004, 60: 6901 - 12
Nuzillard JM.Boumendjel A.Massiot G. Tetrahedron Lett. 1989, 30: 3779 - 13
Blanchette MA.Choy W.Davis JT.Essenfeld AP.Masamune S.Roush WR.Sakai T. Tetrahedron Lett. 1984, 25: 2183 - 14
Still WC.Gennari C. Tetrahedron Lett. 1983, 24: 4405 - 15 Olefination of an aldehyde similar
to 12 by use of the Ando reagent gave the
desired product as a Z/E mixture (9:1) in 70% yield:
see ref. 6g. For the Ando reagent, see:
Ando KJ.Oishi T.Hirama M.Ohno H.Ibuka T. J. Org. Chem. 2000, 65: 4745 - 16
Still WC.Kahn M.Mitra A. J. Org. Chem. 1978, 43: 2923
References
Novartis AG, Annual Report, file no. 1-15024, Form 20-F, Jan 28, 2005, p 42.